Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of osteopenia with melatonin: Effects on bone mineral density, muscle strength and quality of life
2011-004670-28Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of melatonin in osteopenia and osteoporosis, sponsored by Aarhus University Hospital. Primary endpoint: Increase in bone mineral density. Started Apr 2012; status: completed.
02
Drugs
melatonin
03
Conditions
osteopeniaosteoporosis
Beyond the preview
Go deeper on 2011-004670-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004670-28.